Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Lineage Cell Therapeutics
LCTX
$268M
| $4.82M | ﹤0.01% |
3,253,056
+317,245
| +11% | +$360K |
|
2727
Acacia Research
ACTG
$455M
| $4.81M | ﹤0.01% |
902,479
+18,579
| +2% | +$77.5K |
|
|
ITIC
2728
Investors Title Co
ITIC
$530M
| $4.8M | ﹤0.01% |
29,385
+760
| +3% | +$122K |
|
|
RSVR
2729
Reservoir Media
RSVR
$646M
| $4.8M | ﹤0.01% |
604,613
+35,163
| +6% | +$250K |
|
2730
TTEC Holdings
TTEC
$77.4M
| $4.79M | ﹤0.01% |
461,859
+6,550
| +1% | +$110K |
|
2731
American Coastal Insurance
ACIC
$465M
| $4.79M | ﹤0.01% |
447,826
+15,438
| +4% | +$175K |
|
2732
Greif Class B
GEF.B
$4.24B
| $4.77M | ﹤0.01% |
68,605
-1,439
| -2% | -$92.4K |
|
2733
Omeros
OMER
$1.26B
| $4.75M | ﹤0.01% |
1,378,077
+39,364
| +3% | +$150K |
|
|
NVEI
2734
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $4.75M | ﹤0.01% |
145,375
+21,153
| +17% | +$535K |
|
2735
Village Super Market
VLGEA
$627M
| $4.73M | ﹤0.01% |
165,166
+1,648
| +1% | +$43.3K |
|
2736
BayCom
BCML
$341M
| $4.72M | ﹤0.01% |
229,065
+523
| +0.2% | +$10.8K |
|
|
ESPR
2737
DELISTED
Esperion Therapeutics
ESPR
| $4.7M | ﹤0.01% |
1,753,193
+640,947
| +58% | +$1.56M |
|
|
AGEN
2738
Agenus
AGEN
$315M
| $4.7M | ﹤0.01% |
404,981
+9,603
| +2% | +$127K |
|
2739
OptimizeRx
OPRX
$165M
| $4.69M | ﹤0.01% |
385,838
+7,325
| +2% | +$106K |
|
2740
Riley Exploration Permian
REPX
$786M
| $4.67M | ﹤0.01% |
141,584
+2,178
| +2% | +$54.5K |
|
2741
Actinium Pharmaceuticals
ATNM
$30.2M
| $4.67M | ﹤0.01% |
595,720
+26,171
| +5% | +$168K |
|
2742
CVRx
CVRX
$78.3M
| $4.66M | ﹤0.01% |
256,130
+6,587
| +3% | +$156K |
|
2743
Future Fuel
FF
$249M
| $4.63M | ﹤0.01% |
574,754
+17,700
| +3% | +$109K |
|
|
ITI
2744
DELISTED
Iteris, Inc.
ITI
| $4.58M | ﹤0.01% |
926,388
+53,202
| +6% | +$263K |
|
2745
Zevra Therapeutics
ZVRA
$664M
| $4.57M | ﹤0.01% |
787,020
+57,841
| +8% | +$356K |
|
2746
American Well
AMWL
$215M
| $4.56M | ﹤0.01% |
280,983
+1,324
| +0.5% | +$28.4K |
|
|
FRGE
2747
DELISTED
Forge Global Holdings
FRGE
| $4.54M | ﹤0.01% |
156,764
+2,960
| +2% | +$92.4K |
|
|
CVLY
2748
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $4.54M | ﹤0.01% |
199,296
+9,821
| +5% | +$230K |
|
|
NVMI
2749
Nova
NVMI
$13.1B
| $4.5M | ﹤0.01% |
25,382
+967
| +4% | +$153K |
|
2750
Weyco Group
WEYS
$446M
| $4.5M | ﹤0.01% |
141,114
+3,655
| +3% | +$115K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.